Psychopharmacology
February 18, 2022
Dimitri Daldegan-Bueno, Lucas Oliveira Maia, Carolina Marcolino Massarentti et al.
RationaleSmoking-related disease is a major problem globally. Effective smoking cessation treatments are however limited. Increasing evidence suggests that psychedelics have potential as treatments for substance use disorders and may therefore prove an option in aiding smoking cessation.ObjectivesTo establish which factors predict smoking cessation in people who reported quitting or reducing...
Human Psychopharmacology: Clinical and Experimental
February 17, 2022
Edward James, Joachim Keppler, Ben Sessa et al.
41 citations
Abstract Objective Reports have indicated possible uses of ayahuasca for the treatment of conditions including depression, addictions, post‐traumatic stress disorder, anxiety and specific psychoneuroendocrine immune system pathologies. The article assesses potential ayahuasca and N,N‐dimethyltryptamine (DMT) integration with contemporary healthcare. The review also seeks to provide a summary of...
February 14, 2022
Daniel Perkins, Simon Ruffell, Kimberley Day et al.
1 citation
preprint
Ayahuasca is a psychoactive Amazonian plant brew. It is usually made from the Banisteriopsis caapi vine, which contains three primary harmala alkaloids, along with the leaves of Psychotria viridis in which the potent psychedelic dimethyltryptamine (DMT) is found. DMT-harmaloid concoctions have gained popularity in recent years, due to growing anecdotal and scientific reports of therapeutic...
Human Psychopharmacology: Clinical and Experimental
February 2, 2022
Rafael G. Dos Santos, Juliana Mendes Rocha, Giordano Novak Rossi et al.
20 citations
Abstract Objective To assess endocannabinoid (anandamide, AEA; 2‐arachidonoylglycerol, 2‐AG) plasma levels in healthy volunteers and in volunteers with social anxiety disorder (SAD) after a single oral dose of ayahuasca or placebo. Methods Post hoc analysis of endocannabinoid plasma levels (baseline, 90 and 240 min after drug intake) from two parallel‐group, randomized, placebo‐controlled...
Psychopharmacology
January 24, 2022
Kim van Oorsouw, S. W. Toennes, J. G. Ramaekers
71 citations
RATIONALE: Studies have suggested mental health improvements following the use of the psychotropic plant concoction ayahuasca in non-clinical and clinical samples. OBJECTIVES: The present observational study assessed depressive symptomatology in 20 clinically depressed patients (symptom score > 13 on the Beck's Depression Inventory) before attendance of an ayahuasca ceremony and 1 month and 1...
Transcultural Psychiatry
January 6, 2022
Eduardo Ekman Schenberg, Konstantin Gerber
18 citations
After decades of biomedical research on ayahuasca's molecular compounds and their physiological effects, recent clinical trials show evidence of therapeutic potential for depression. However, indigenous peoples have been using ayahuasca therapeutically for a very long time, and thus we question the epistemic authority attributed to scientific studies, proposing that epistemic injustices were...
Entre trópicos
2022
Mauricio Guzmán, Beatriz C. Labate
Este capítulo apresenta a reflexão sobre os contatos e intercâmbios entre usuários de ayahuasca e de peiote em contextos rituais no México. Diferentemente do que opinam outros autores, os contatos e usos alternados ou combinados dessas substâncias enteógenas não acontecem de forma descontextualizada, constante ou desterritorializada. Essas novas formas revelam negociações ou acordos...
Journal de la Société des Américanistes
2022
Doriane Slaghenauffi
2 citations
L’émergence du « tourisme chamanique » dans certaines zones urbaines et dans des villages shipibo-konibo est à l’origine d’une recrudescence des pratiques sorcellaires vernaculaires, désormais intégrées au nouveau contexte sociologique de commercialisation du chamanisme végétaliste local. Ces attaques occultes visent non seulement des praticiens rivaux mais aussi des touristes en quête d’une...
ABSTRACT BOOK 2022
2022
Objetivos: Caso altamente probable de Psicosis inducida por Ayahuasca en nuestro país. Material y Métodos: Caso clínico atendido en Unidad de Hospitalización de adultos. Resultados y conclusiones: Mujer de 51 años de edad, natural de la provincia de Zaragoza. Casada hace 25 años, dos hijos de 21 y 24. Peluquera en un pueblo de la misma provincia. Círculo social adecuado. Sin antecedentes de...
ABSTRACT BOOK 2022
2022
La ayahuasca es una bebida psicoactiva compuesta por dos plantas que tienen su crecimiento en la selva amazónica (Banisteriopssis caapi o yagé y Psychotria viridis o chacruna).Esta última contiene el principio psicoactivo DMT, causante de intensas alucinaciones. Se presenta el caso de un varón de 33 años de nacionalidad británica que acude al servicio de urgencias psiquiátricas por alteraciones...